METHOD FOR TREATING OR PREVENTING THROMBOSIS USING DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED EFFICACY OVER CONVENTIONAL WARFARIN THERAPY

METHOD FOR TREATING OR PREVENTING THROMBOSIS USING DABIGATRAN ETEXILATE OR A SALT THEREOF WITH IMPROVED SAFETY PROFILE OVER CONVENTIONAL WARFARIN THERAPY

PHARMACEUTICAL COMPOSITION OF ORLISTAT

Nanofunctional silica particles and manufacturing method thereof

PHARMACEUTICAL COMPOSITIONS COMPRISING N-[2-(DIETHYLAMINO)ETHYL]-5-[(5-FLUORO-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE

Emulsion compositions

Antimicrobial composition comprising pyrogenic silica and serratiopeptidase

MILNACIPRAN FORMULATIONS

SOLID PHARMACEUTICAL COMPOSITION COMPRISING 1-(4-CHLOROANILINO)-4-(4-PYRIDYLMETHYL)PHTHALAZINE AND A PH MODIFIER

Method for treating celiac disease

Controlled release oral dosage form

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

Magnetic particles for delivering therapeutic agent to a target location

Powder and its method of manufacture

Particles containing an active agent in the form of a co-precipitate

Core particle for pharmaceutical preparation

Controlled release matrix pharmaceutical dosage formulation

Spherical Particle and Method for Producing the Same

Method of drug formulation of compositions comprising crystalline microparticle surfaces

LOW DOSE SUBLINGUAL TABLETS OF OPIOID ANALGESICS AND PREPARATION PROCESS

Cellulose-based fine core particle and process for producing the same

MICROPARTICLE FORMULATIONS FOR SUSTAINED-RELEASE OF BIOACTIVE COMPOUNDS

DEVICE FOR THE ORAL ADMINISTRATION OF ACTIVE INGREDIENTS

ORAL INSULIN COMPOSITION AND METHODS OF MAKING AND USING THEREOF

PHARMACEUTICAL DOSAGE FORMS AND METHODS OF MANUFACTURING SAME

ORAL INSULIN COMPOSITION AND METHODS OF MAKING AND USING THEREOF

Coated preparation

Emulsion compositions

Venlafaxine Formulations and Methods of Preparing the Same

PHARMACEUTICAL COMPOSITIONS OF POORLY SOLUBLE DRUGS

Compositions Comprising Melperone

Gastric acid secretion inhibiting composition

Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist

Sustained Release Particulate Oral Dosage Forms of (R)-Baclofen and Methods of Treatment

PHARMACEUTICAL COMPOSITIONS OF DICLOFENAC AND MISOPROSTOL

Non-abusable pharmaceutical composition comprising opioids

Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent

COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS

COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS

NOVEL STABLE BEADLETS OF LIPOPHILIC NUTRIENTS

Pharmaceutical composition containing fenofibrate and method for the preparation thereof

Pharmaceutical Compositions Containing Diacerein

Abuse-resistant oral dosage forms and method of use thereof

Abuse-Resistant Dosage Form

Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them

Methods and compositions for delivering peptides

MODIFIED DOSAGE FORMS OF TACROLIMUS

PELLETS CONTAINING A PHARMACEUTICAL SUBSTANCE, METHOD FOR THE PRODUCTION THEREOF AND USE OF THE SAME

Stable fixed dose topical formulation

Process for preparing particles containing an antiviral

ORGANIC COMPOUNDS

Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate

Taste-masking solid preparation of pioglitazone

Microphasic micro-components and methods for controlling morphology via electrified jetting

Novel acetysalicylic acid formulations

Granule and preparation method thereof

COMPOSITION AND COMBINATIONS OF CARBOXYLIC ACID LOSARTAN IN DOSAGE FORMS

Method for producing spherical base granules comprising hardly water-soluble drug

Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor

COMBINATION OF A TRIPTAN AND AN NSAID

NOVEL TOPIRAMATE COMPOSITIONS AND AN ESCALATING DOSING STRATEGY FOR TREATING OBESITY AND RELATED DISORDERS

DRUG DELIVERY COMPOSITION

Escalating dosing regimen for effecting weight loss and treating obesity

BIODEGRADABLE BLOCK COPOLYMERS WITH MODIFIABLE SURFACE

Process for producing spherical base granule comprising easily water-soluble drug

Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing said form of administration

Rehydratable pharmaceutical product

Nanoparticulate and Controlled Release Compositions Comprising a Cephalosporin

TASTE-MASKED PHARMACEUTICAL COMPOSITIONS PREPARED BY COACERVATION

COMPOSITIONS COMPRISING WEAKLY BASIC DRUGS AND CONTROLLED-RELEASE DOSAGE FORMS

Nanoencapsulation and Release of Nucleic Acids

Particle for medical use and process for producing the same

Abuse-resistant oral dosage forms and method of use thereof

Cell Transport Compositions and Uses Thereof

Drug delivery systems comprising weakly basic drugs and organic acids

Method and process for the production of multi-coated recognitive and releasing systems

Stable Oral Pharmaceutical Composition Containing Thyroid Hormone Receptor Agonists

TRANEXAMIC ACID FORMULATIONS WITH REDUCED ADVERSE EFFECTS

Sustained Release Particulate Oral Dosage Forms of (R) Baclofen and Methods of Treatment

SPHERICAL ELEMENTARY GRANULE AND METHOD FOR PRODUCTION THEREOF

PHARMACEUTICAL COMPOSITIONS OF ATORVASTATIN

Utilization of dialkylfumarates

Utilization of dialkylfumarates

Pharmaceutical compositions

Pharmaceutical composition

Compositions and Methods for Enhancement of Sexual Function

Methods and compositions for needleless delivery of particles

Chronic, Bolus Adminstration Of D-Threo Methylphenidate

Paliperidone sustained release formulation

Extended release venlafaxine formulation

Metal oxide coating of water insoluble ingredients

Therapeutic regimens for the treatment of immunoinflammatory disorders

SOLID CARRIERS FOR IMPROVED DELIVERY OF ACTIVE INGREDIENTS IN PHARMACEUTICAL COMPOSITIONS

Method for treating menorrhagia

MICROSPHERES WITH SURFACE PROJECTIONS

BETA-1-SELECTIVE ADRENOCEPTOR BLOCKING AGENT COMPOSITIONS AND METHODS FOR THEIR PREPARATION

Method of increasing the extent of absorption of tizanidine

MEDICINE FOR TREATMENT OF CARCINOMA

Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases

Delayed release formulations of 6-mercaptopurine

Process for preparation of swellable and degradable microspheres

Fenofibrate compositions

Stabilized tolterodine tartrate formulations

Oral pharmaceutical dosage form and manufacturing method thereof

Drug carrier pellet production process

METHOD OF REDUCING SOMNOLENCE IN PATIENTS TREATED WITH TIZANIDINE

Compositions controlling pH range of release and/or release rate

Spherical Menthol Particles

Tamper-resistant oral opioid agonist formulations

Tamper-resistant oral opioid agonist formulations

Tamper-resistant oral opioid agonist formulations

Tamper-resistant oral opioid agonist formulations

Ziprasidone formulations

Nanoparticle/active ingredient conjugates

Photocatalytic Titanium Dioxide Microparticle, Dispersion Liquid Thereof and Process for Producing the Same

Composite and layered particles for efficient delivery of polyelectrolytes

GLUCAGON-LIKE PEPTIDE 1 (GLP-1) PHARMACEUTICAL FORMULATIONS

PHARMACEUTICAL COMPOSITION OF TOPIRAMATE

Method of Making Dried Particles

Pharmaceutical composition containing fenofibrate and method for the preparation thereof

Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist

Tablets with Improved Dissolution Profile

Cross-linked polymer particles

Method and process for the production of multi-coated recognitive and releasing systems

MULTIPARTICULATE CONTROLLED RELEASE SELECTIVE SEROTONIN REUPTAKE INHIBITOR FORMULATIONS

Controlled-release formulation of piperazine-piperidine antagonists and agonists of the 5-HT1A receptor having enhanced intestinal dissolution

Taste masked dosage form containing roflumilast

Emulsion compositions

Microparticles

COMPOSITIONS FOR ORAL DELIVERY OF PHARMACEUTICALS

Abuse-resistant oral dosage forms and method of use thereof

Oral Dosage Form Comprising Rosiglitazone

Method for producing granules

Granule formation

Nanoparticulate and controlled release compositions comprising cyclosporine

APOPTOSIS-MIMICKING SYNTHETIC ENTITIES AND USE THEREOF IN MEDICAL TREATMENT

Sustained-release formulations of topiramate

Modified Release of Compositions Containing a Combination of Carbidopa, Levodopa and Entacapone

Pharmaceutical Solid Dosage Forms Comprising Amorphous Compounds Micro-Embedded in Ionic Water-Insoluble Polymers

Stable Particular Pharmaceutical Composition of Solifenacin or Salt Thereof

COMPOSITIONS COMPRISING NANOPARTICULATE MELOXICAM AND CONTROLLED RELEASE HYDROCODONE

DNA DOSAGE FORMS

Controlled Release Compositions Comprising a Cephalosporin for the Treatment of a Bacterial Infection

Process for preparing fenofibrate compositions

Fenofibrate compositions

Formulation and process for drug loaded cores

New Indications for Direct Thrombin Inhibitors in the Cardiovascular Field

Low-dose tablets having a network of polymers

COMPOSITIONS OF 5-HT3 ANTAGONISTS AND DOPAMINE D2 ANTAGONISTS FOR TREATMENT OF DOPAMINE-ASSOCIATED CHRONIC CONDITIONS

Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions

Fibrin adhesive granulate and method for its preparation

Biodegradable block copolymers with modifiable surface

Biodegradable block copolymers with modifiable surface

Biodegradable block copolymers with modifiable surface

Silylamine modified nanoparticulate carriers

Therapeutic calcium phosphate particles and methods of manufacture and use

LOW DOSE TABLETS OF OPIOID ANALGESICS AND PREPARATION PROCESS

Microparticles and methods for production thereof

Solid Products with Improved Stability and Method for Producing the Same

Controlled dose drug delivery system

Utilization of dialkylfumarates

Utilization of dialkylfumarates

Pharmaceutical formulations containing a non-steroidal antinflammatory drug and an antiulcerative drug

Method for preparing free base compositions and formulations thereof

Novel Pharmaceutical Dosage Form and Manufacturing Process

Apoptosis-mimicking synthetic entities and use thereof in medical treatment

Compositions and Methods for Reducing Inflammation and Pain Associated with Acidosis

Controlled Release Matrix Pharmaceutical Dosage Formulation

DOSAGE FORMS

Formulations for a tight junction effector

Process for producing fenofibrate tablets

Process for producing fenofibrate tablets

Taste masked compositions of erythromycin a and derivatives thereof

Modified release oral dosage form using co-polymer of polyvinyl acetate

Pharmaceutical composition comprising anticonvulsant with taste mask coating

Solid ganaxolone formulations and methods for the making and use thereof

Method of preparation of oral solid dosage form with instant release of acting

Liquid ganaxolone formulations and methods for the making and use thereof

Venlafaxine formulations and methods of preparing the same

MODIFIED AND PULSATILE RELEASE PHARMACEUTICAL FORMULATIONS OF ESCITALOPRAM

GALANTAMINE COMPOSITIONS

EFFERVESCENT FORMULATIONS OF OXYTOCIN

Pharmaceutical composition containing fenofibrate and method for the preparation thereof

MODIFIED AND IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE

Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces

Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents

Microcapsules by coacervation containing a pharmaceutical incorporated in the coating polymer

Composite nanoparticles

Gastric acid secretion inhibiting composition

Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form

Method of producing dosage units of a solid drug form containing warfarin sodium salt as active component

PHARMACEUTICAL COMPOSITIONS COMPRISING FENOFIBRATE AND ATORVASTATIN

Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent

WATER SOLUBLE ANALGESIC FORMULATIONS AND METHODS FOR PRODUCTION

PHARMACEUTICAL COMPOSITION OF TOPIRAMATE

Coated tablets

Composition for inducing sleep comprising essential oils as active ingredients, a percutaneous pharmaceutical agent comprising thereof, and a process for producing thereof

Timed, pulsatile release systems

Sustained release pharmaceutical composition

Vaccines

Particles containing an acitve agent in the form of a co-precipitate

Process for producing nanoparticles by spray drying

Amphetamine formulations

Solid dispersion of tacrolimus

Process for preparing particles containing an antiviral

Oral compositions for the stimulation of gastric acid secretion comprising pentagastrin

Antidepressant oral pharmaceutical compositions

Granular composition and process for producing the same

Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof

Nucleic acid coated particles suitable for temporary storage

Drug microparticles

Drug microparticles

Drug microparticles

Lercanidipine immediate release compositions

Gastric acid secretion inhibiting composition

Taste-masked pharmaceutical compositions prepared by coacervation

Formulations for treating or preventing mucositis

Method of drug delivery to interstitial regions of the myocardium

Therapeutic calcium phosphate particles for use in inhibiting expression of a gene

Orally disintegrating tablets of atomoxetine

Pharmaceutical dosage forms having immediate release and/or controlled release properties

Stable solid preparations

Controlled regional oral delivery

Taste masked dosage forms and processes for their preparation

Tamper-resistant oral opioid agonist formulations

Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Effervescent formulations of oxytocin

Method of treating attention deficit disorders with d-threo methylphenidate

Method of drug delivery to interstitial regions of the myocardium

Formulations of 6-mercaptopurine

Delayed release formulations of 6-mercaptopurine

Chronotherapeutic compositions and methods of their use

Polymeric drug delivery system for hydrophobic drugs

Delayed delivery system for acid-sensitive drugs

Proton pump inhibitor formulations, and methods of preparing and using such formulations

Donepezil formulations

Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist

Composition comprising itraconazole for oral administration

Microparticles with adsorbed polypeptide-containing molecules

Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist

Pharmaceutical dosage forms having controlled release properties that contain a GABAB receptor agonist

Cardiac drug delivery system and method of use

Stable pharmaceutical composition comprising an acid labile drug

Stable pharmaceutical composition comprising an acid labile drug

Microparticle formulations for sustained-release of bioactive compounds

Abuse-safeguarded dosage form

Abuse-proofed dosage form

Tamper-resistant oral opioid agonist formulations

Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and an antiulcerative drug

Process for producing a pharmaceutical solid preparation containing a poorly soluble drug

Controlled release oral dosage form

Oral dosage formulations of active pharmaceutical ingredients and methods of preparing the same

Composition comprising a liquid absorbed on a support based on precipitated silica

Pharmaceutical composition containing water soluble drug

Azithromycin multiparticulate dosage forms by liquid-based processes

Microparticles

Apoptosis-mimicking synthetic entities and use thereof in medical treatment

Method of treating attention deficit disorders with D-threo methylphenidate

Drug coating providing high drug loading

Surface roughness quantification of pharmaceuticals, herbal, nutritional dosage forms and cosmetic preparations

Extended release venlafaxine formulation

Controlled release formulation of tamsulosin hydrochloride and preparation process thereof

Stable beadlets of lipophilic nutrients

Administration form for the oral application of poorly soluble drugs

Tamper-resistant oral opioid agonist formulations

Dna dosage forms

Dna dosage forms

Method for producing microparticles loaded with proteins

Extended release formulations of opioids and method of use thereof

Emulsion compositions

Chronic, bolus administration of D-threo methylphenidate

Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders

Process for forming amorphous atorvastatin

Sustained release pharmaceutical composition

Particle-mediated delivery of antigens

Method for formulating healthcare products with enhanced stability

Preformulation for tabletting natural mixtures of conjugated estrogens

Formulation and process for drug loaded cores

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Methods of administering gamma hydroxybutyrate formulations after a high-fat meal

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Duloxetine sprinkles

Abuse resistant pharmaceutical compositions